Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol f
EU CT 2024-512017-12-00. Registered on October 24th, 2024; ClinicalTrials.gov NCT06653634. Registered on October 24th, 2024. URL: Study Details | NCT06653634 | Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial | ClinicalTrials.gov. Date of first recruitment: October 24th, 2024.
Authors
- Maiju Pesonen (ORCID: https://orcid.org/0000-0002-3399-2136)
- Nina Krafft Sande (ORCID: https://orcid.org/0000-0003-3461-9525)
- Cathrine Austad
- Siri Opsahl Hetlevik (ORCID: https://orcid.org/0000-0001-9553-2322)
- Berit Flatø (ORCID: https://orcid.org/0000-0002-5207-9182)
- Siri Lillegraven (ORCID: https://orcid.org/0000-0003-3615-0134)
- Vibke Lilleby (ORCID: https://orcid.org/0000-0002-4944-0328)
- E. Haavardsholm
- Hege Kilander Høiberg
- Pernille Bøyesen (ORCID: https://orcid.org/0000-0002-9751-5144)
- Maria Karolina Jonsson
- Anna-Birgitte Aga
- M. Bilstad
- Marite Rygg
- Athimalaipet V. Ramanan
Institutions
- Oslo University Hospital (NO)
- University Hospital of North Norway (NO)
- University of Oslo (NO)
- Norwegian University of Science and Technology (NO)
- Stavanger University Hospital (NO)
- Vestre Viken Hospital Trust (NO)
- Haukeland University Hospital (NO)
- Bristol Royal Hospital for Children (GB)
- Hospital of Southern Norway (NO)
- University of Bristol (GB)
- St Olav's University Hospital (NO)
- Diakonhjemmet Hospital (NO)
- Sørlandet Sykehus (NO)
- UiT The Arctic University of Norway (NO)
Publication Details
- Journal
- Trials
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1186/s13063-026-09539-0
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00